Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03613532
Title Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Jacqueline Garcia, MD
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST